Rat atrial natriuretic peptide stimulates K+ fluxes in human erythrocytes

Eur J Pharmacol. 1989 Jul 18;166(2):349-52. doi: 10.1016/0014-2999(89)90082-4.

Abstract

Ouabain- and bumetanide-resistant potassium fluxes were measured in human erythrocytes incubated in a medium containing calcium and a calcium ionophore. Pharmacological concentrations of rat atrial natriuretic peptide stimulated these fluxes. Although human erythrocytes lack atrial natriuretic peptide receptors, our results suggest that the hormone can modify transmembrane K+ movements.

MeSH terms

  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Bumetanide / pharmacology
  • Calcimycin / pharmacology
  • Calcium / pharmacology
  • Egtazic Acid / pharmacology
  • Erythrocytes / drug effects
  • Erythrocytes / metabolism*
  • Humans
  • In Vitro Techniques
  • Ouabain / pharmacology
  • Potassium / blood*
  • Quinine / pharmacology
  • Rats

Substances

  • Bumetanide
  • Calcimycin
  • Egtazic Acid
  • Ouabain
  • Atrial Natriuretic Factor
  • Quinine
  • Potassium
  • Calcium